Current and historical daily PE Ratio for Genovate Biotechnology Co Ltd (
) from 2012 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Genovate Biotechnology stock (ROCO:4130) PE ratio as of Jun 10 2024 is 80.83.
More Details
Genovate Biotechnology Co Ltd (ROCO:4130) PE Ratio (TTM) Chart
Genovate Biotechnology Co Ltd (ROCO:4130) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1208
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Genovate Biotechnology PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 80.8 | 2024-04-03 | 83.3 |
| 2024-06-07 | 80.8 | 2024-04-02 | 83.7 |
| 2024-06-06 | 80.8 | 2024-04-01 | 83.5 |
| 2024-06-05 | 81.2 | 2024-03-29 | 83.0 |
| 2024-06-04 | 80.5 | 2024-03-28 | 83.5 |
| 2024-06-03 | 80.8 | 2024-03-27 | 92.6 |
| 2024-05-31 | 80.2 | 2024-03-26 | 92.2 |
| 2024-05-30 | 80.0 | 2024-03-25 | 92.2 |
| 2024-05-29 | 80.3 | 2024-03-22 | 92.2 |
| 2024-05-28 | 80.8 | 2024-03-21 | 91.5 |
| 2024-05-27 | 79.8 | 2024-03-20 | 91.7 |
| 2024-05-24 | 80.0 | 2024-03-19 | 92.4 |
| 2024-05-23 | 79.8 | 2024-03-18 | 93.0 |
| 2024-05-22 | 80.3 | 2024-03-15 | 93.0 |
| 2024-05-21 | 80.5 | 2024-03-14 | 93.3 |
| 2024-05-20 | 81.3 | 2024-03-13 | 93.2 |
| 2024-05-17 | 80.7 | 2024-03-12 | 93.2 |
| 2024-05-16 | 79.7 | 2024-03-11 | 93.0 |
| 2024-05-15 | 79.7 | 2024-03-08 | 92.8 |
| 2024-05-14 | 79.7 | 2024-03-07 | 95.2 |
| 2024-05-13 | 79.0 | 2024-03-06 | 95.4 |
| 2024-05-10 | 79.5 | 2024-03-05 | 95.4 |
| 2024-05-09 | 79.5 | 2024-03-04 | 96.3 |
| 2024-05-08 | 80.3 | 2024-03-01 | 97.4 |
| 2024-05-07 | 80.2 | 2024-02-29 | 95.6 |
| 2024-05-06 | 80.0 | 2024-02-27 | 95.6 |
| 2024-05-03 | 80.2 | 2024-02-26 | 95.6 |
| 2024-05-02 | 81.5 | 2024-02-23 | 94.8 |
| 2024-04-30 | 81.5 | 2024-02-22 | 96.7 |
| 2024-04-29 | 81.2 | 2024-02-21 | 94.8 |
| 2024-04-26 | 80.2 | 2024-02-20 | 94.8 |
| 2024-04-25 | 80.3 | 2024-02-19 | 94.4 |
| 2024-04-24 | 81.0 | 2024-02-16 | 94.8 |
| 2024-04-23 | 80.8 | 2024-02-15 | 93.9 |
| 2024-04-22 | 79.7 | 2024-02-05 | 90.2 |
| 2024-04-19 | 79.3 | 2024-02-02 | 92.2 |
| 2024-04-18 | 81.0 | 2024-02-01 | 92.4 |
| 2024-04-17 | 80.5 | 2024-01-31 | 92.6 |
| 2024-04-16 | 79.8 | 2024-01-30 | 93.0 |
| 2024-04-15 | 81.8 | 2024-01-29 | 94.1 |
| 2024-04-12 | 83.2 | 2024-01-26 | 94.3 |
| 2024-04-11 | 83.5 | 2024-01-25 | 94.4 |
| 2024-04-10 | 84.3 | 2024-01-24 | 95.2 |
| 2024-04-09 | 83.5 | 2024-01-23 | 94.8 |
| 2024-04-08 | 83.5 | 2024-01-22 | 94.3 |
Genovate Biotechnology Co Ltd (ROCO:4130) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Genovate Biotechnology Co Ltd
NAICS : 325412
SIC : 2834
ISIN : TW0004130000
Description
Genovate Biotechnology Co Ltd develops, manufactures and markets pharmaceutical preparations, drug substances and intermediates. Its product line includes nervous system drugs, digestive system drugs and cardiovascular system drugs, among others. It also provides clinical trial services for various drugs.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers